Advertisement

Topics

Typhoid Vaccine Wyeth - Biotech, Pharma and Life Science Channel

00:32 EDT 25th August 2016 | BioPortfolio

PubMed Articles [1498 Associated PubMed Articles listed on BioPortfolio]

African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004-2014.

African horse sickness (AHS) is a hemorrhagic viral fever of horses. It is the only equine disease for which the World Organization for Animal Health has introduced specific guidelines for member coun...

Imitation dynamics of vaccine decision-making behaviours based on the game theory.

Based on game theory, we propose an age-structured model to investigate the imitation dynamics of vaccine uptake. We first obtain the existence and local stability of equilibria. We show that Hopf bif...

In silico proposition to predict cluster of B- and T-cell epitopes for the usefulness of vaccine design from invasive, virulent and membrane associated proteins of C. jejuni.

Campylobacter jejuni is the one of the leading causes of bacterial diarrheal illness worldwide. This study aims to design specific epitopes for the utility of designing peptide vaccine(s) against C. j...

Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine.

Mucosal immune system plays a very important role in antiviral immune response. We prepared Newcastle disease viruses (NDV) encapsulated in N-2-hydroxypropyl trimethyl ammonium chloride chitosan (N-2-...

Evolving Immunotherapy Approaches for Renal Cell Carcinoma.

Metastatic renal cell carcinoma (mRCC) continues to be associated with high rates of morbidity and mortality. Renal cell carcinoma (RCC) is typically resistant to cytotoxic chemotherapy, and while tar...

An oral cholera vaccine for travelers (Vaxchora).

HHS Moves to Accelerate Zika Vaccine Development.

Human Papillomavirus Vaccination Requirements in US Schools: Recommendations for Moving Forward.

Safe and effective human papillomavirus (HPV) vaccines have been available and recommended for adolescents for a decade in the United States, yet vaccination rates remain suboptimal. School entry requ...

Reply letter and clarifications on behalf of La Rosa and collegues to Sicilian Public health authorities.

In May 2016 we published in the journal "Human Vaccines and Immunotherapy. 1 79 80" the case-report "Post-rotavirus vaccine intussusception in identical twins: a case report". We received a reply lett...

Vaccine adjuvants: why and how.

Novel vaccine strategies include the so-called subunit vaccines, which encompass only the part of the pathogen to which immune recognition results in protection. The high purity of these vaccines make...

News Articles [2328 Associated News Articles listed on BioPortfolio]

BRIEF-Pulike Biological Engineering to cooperate with the Spirit Jinyu Biological Pharmaceutical on foot and mouth disease vaccine research

* Says it signs agreement to cooperate with the Spirit Jinyu Biological Pharmaceutical Co., Ltd on a new foot and mouth disease vaccine research and development

Seqirus to highlight new data in seasonal influenza prevention at Options IX for the Control of Influenza conference

MAIDENHEAD, United Kingdom, Aug. 24, 2016 /PRNewswire/ -- Seqirus announced today that seven poster presentations reporting results of the company's research and development in seasonal influenza...

Public Health Roundup: Growing Number Of Young Stroke Victims; Roadblocks In Mental Health Care

News outlets also report on parents' attitude toward the HPV vaccine, how job satisfaction impacts health later in life, the connection between online devices and sleep quality as well as the latest o...

Seqirus Presents Integrated Analyses for Trivalent Adjuvanted Seasonal Influenza Vaccine for ...

"Seqirus is proud to contribute to the body of evidence supporting the use of adjuvanted vaccines to help protect children from seasonal influenza," said Russell Read more...

Using cold adaptation to produce safe inactivated polio vaccine candidates

Poliomyelitis, or polio, is a debilitating childhood disease caused by poliovirus. It has been eliminated from most parts of the world thanks to the extensive use of polio vaccines. However, there are...

LISTEN: Can scientists keep pace with Zika to develop a vaccine?

This episode of Signal explores the race to protect humanity from Zika as epidemiologists and vaccine manufacturers work fast to develop a vaccine.

Seqirus Presents Integrated Analyses for Trivalent Adjuvanted Seasonal Influenza Vaccine for Young Children

MAIDENHEAD, United Kingdom, Aug. 24, 2016 /PRNewswire/ -- Seqirus today announced results of two data integrated analyses from six randomized clinical trials evaluating the safety and immuno...

While working on its HIV Cure, Gilead gives Europe an ‘HIV Vaccine’

Despite progress in HIV treatments and towards an HIV cure, the infection rate has risen to unprecedented levels in Europe. Gilead’s HIV-1 ‘vaccine’, Truvada, has just been approved for ...

Medical News Today: Flu Shot: Side Effects, Facts, Things to Consider

Does the flu shot cause side effects? This article looks at what the flu shot is, how safe it is, and when people should get this vaccine.

Medical News Today: Zika clone promises to assist vaccine development

Viruses are notoriously difficult to predict. A newly designed Zika clone might be the tool needed to produce a reliable vaccine and halt the pandemic.

Events [0 Results]

None

Companies [99 Associated Companies listed on BioPortfolio]

IDT Biologika and CMC Biologics

IDT Biologika is an innovative life science company headquartered in Dessau, Germany with extensive expertise in research, development and manufacturing of vaccines, and in additi...

TOMTEC

Tomtec has succeeded since 1967 by working with its clients to help solve their liquid handling needs. From 1967 to 1981, the Company had essentially one employee, Tom Astle. From 1967 to 1971, the Co...

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics is an Oxford, UK-based development stage biotechnology company with a particular focus on immune therapeutics in oncology. PsiOxus has developed a pate...

Neon Therapeutics

Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine will allo...

VaxAlta Inc.

VaxAlta is a leading glycoconjugate vaccine research and development company based in Edmonton, Alberta. Founded in 2013, the company is focused on developing sugar-based, effecti...

IDT Biologika

IDT Biologika is an innovative, privately-held life science company with more than 94 years history and expertise in Research, Development and Manufacturing of biologics for the g...

ImmusanT, Inc.

ImmusanT is a privately held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagn...

FluGen, Inc.

FluGen, Inc. is a privately held biotechnology company founded in 2005 and based in Madison, WI. The company has been developing novel influenza vaccine technology first invented ...

Immunovaccine Inc.

Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented formulation that provides control...

AVAX Technologies, Inc.

AVAX Technologies, Inc. is a biotechnology company with operations in the United States and Europe. The Company is engaged in the research, clinical and commercial development of ...

Clinical Trials [2656 Associated Clinical Trials listed on BioPortfolio]

Partnership for Research on Ebola VACcinations

The purpose of this study is to evaluate the safety and immunogenicity of three vaccine strategies that may prevent Ebola virus disease (EVD) events in children and adults. Participants wi...

The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination

This is a prospective pilot study designed to suggest differences in the immunologic response to the seasonal influenza vaccine in people with regular vaccination history compared to those...

Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30

This study will evaluate the ability of a single dose of the live attenuated recombinant tetravalent dengue vaccine TetraVax-DV-TV005 (referred to as TV005) to protect against infection wi...

RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults

A total of 400 subjects will be recruited into five treatment subject groups à 80 subjects.Subject will receive two administrations 4 weeks apart which will consist of MVA-BN-RSV Dose 1, ...

Safety and Immunogenicity Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

This study evaluates the safety and immunogenicity of the ACYW135 Meningococcal Polysaccharide Vaccine in population aged 2-50 years old. Subjects will be diveded into 3 group according to...

Human Challenge Model With ST-only Enterotoxigenic Escherichia Coli

Heat stable toxin (ST) producing ETEC strains are important causes of childhood diarrhea in many countries. Vaccine candidates targeting ST are in development. A human challenge model usin...

A Study to Evaluate Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction

This project proposes to implement and compare new community pharmacy-based strategies for improving vaccine coverage.

Asymptomatic Flu Project

Although clinical presentation of influenza is often symptomatic, asymptomatic cases also occur. The knowledge of the incidence of asymptomatic influenza among healthcare workers is very i...

Safety of Nasal Influenza Immunisation in Children With Asthma

A new influenza vaccine, known as LAIV (Live Attenuated Intranasal Vaccine) has recently been approved by a number of licensing boards and is given by a spray into the nose. In the United ...

Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

This phase I clinical study evaluates the safety of ACYW135 meningococcal polysaccharide vaccine in population aged 2-6, 7-17, 18-50 years old by the method of both passive and active surv...

Videos

None available.

Medical and Biotech [MESH] Definitions

A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.

A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)

A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.

Vaccines used to prevent TYPHOID FEVER and/or PARATYPHOID FEVER which are caused by various species of SALMONELLA. Attenuated, subunit, and inactivated forms of the vaccines exist.

Quick Search
Advertisement
 
review and buy Typhoid Vaccine Wyeth market research data and corporate reports here

Channels Quicklinks